SDC4 and heart disorder: The present work investigates (i) whether circulating levels of syndecan-4 reflect the cardiac inflammatory status in patients with heart disease, and (ii) the effects of immunomodulatory inhibitors used in clinical practice on syndecan-4 levels and shedding in vitro.